4//SEC Filing
Shmagin Martin E 4
Accession 0001013762-09-000173
CIK 0000932352other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 3:12 PM ET
Size
6.4 KB
Accession
0001013762-09-000173
Insider Transaction Report
Form 4
Urigen Pharmaceuticals, Inc.UGRP.OB
Shmagin Martin E
DirectorChief Financial Officer
Transactions
- Purchase
Common Stock, $.001 Par Value
2009-01-29$0.13/sh+1,000$130→ 3,119,573 total - Purchase
Common Stock, $.001 Par Value
2009-01-29$0.10/sh+3,000$300→ 3,122,573 total
Documents
Issuer
Urigen Pharmaceuticals, Inc.
CIK 0000932352
Entity typeother
Related Parties
1- filerCIK 0001407236
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 3:12 PM ET
- Size
- 6.4 KB